Experienced in Primary Biliary Cholangitis

Mariano Cartier

Hospital De Gastroenterología Dr. Carlos Bonorino Udaondo, Av. Caseros 2061, 
Caseros, B, AR 
Experienced in Primary Biliary Cholangitis
Hospital De Gastroenterología Dr. Carlos Bonorino Udaondo, Av. Caseros 2061, 
Caseros, B, AR 
OverviewLocationsClinical Research

Overview

Mariano Cartier practices in Caseros, Argentina. Mr. Cartier is rated as an Experienced expert by MediFind in the treatment of Primary Biliary Cholangitis. His top areas of expertise are Spontaneous Bacterial Peritonitis, Cirrhosis, Bile Duct Obstruction, and Primary Biliary Cholangitis.

His clinical research consists of co-authoring 8 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 2 clinical trials in the study of Primary Biliary Cholangitis.

Gender
Male

Locations

Hospital De Gastroenterología Dr. Carlos Bonorino Udaondo, Av. Caseros 2061, Caseros, B, Argentina
Other Locations
Hospital De Gastroenterología Dr. Carlos Bonorino Udaondo, Ciudad Autónoma De Buenos Aires 1264, Buenos Aires, C, Argentina
B, Argentina

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
Enrollment Status: Terminated
Publish Date: September 06, 2022
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 4
View 1 Less Clinical Trial

8 Total Publications

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients.
Journal: Digestive diseases and sciences
Published: September 30, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cartier's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile